PTC Therapeutics, Inc. SEC filings PTCT

PTC Therapeutics, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Jun 5, 2017. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Jan 31, 2026. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 20, 2026 Jan 31, 2026
10-K Annual report Feb 19, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
10-K Annual report Feb 27, 2025 Dec 31, 2024
10-K Annual report Feb 29, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 26, 2023 Dec 31, 2022
10-K/A Amended annual report Mar 8, 2023 Dec 31, 2022
10-K Annual report Feb 21, 2023 Dec 31, 2022
10-K Annual report Feb 22, 2022 Dec 31, 2021
10-K Annual report Feb 25, 2021 Dec 31, 2020
10-K Annual report Mar 2, 2020 Dec 31, 2019
10-K Annual report Mar 1, 2019 Dec 31, 2018
10-K Annual report Mar 6, 2018 Dec 31, 2017

Showing 13 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
PTCT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Warren, NJ
SEC filer status
Large accelerated filer
SEC CIK
1070081
Former names
PTC THERAPEUTICS INC (until Oct 12, 2005)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.